HOUSTON, TX--(Marketwired - Feb 4, 2015) - Signal Advance, Inc. (OTC PINK: SIGL) today announced plans to enter the nearly two billion dollar Neural Training market by applying its proprietary Signal Advance ("SA") technology to develop an enhanced Neural Training System. Neural Training (neuro-therapy, neuro-feedback) typically applies auditory, visual, or direct current stimuli to the brain to improve brain function. Effective Neural Training relies on quickly measuring the brain's response to stimuli and making real-time adjustments. In a University study, SA circuit designs were shown to reduce delays in measuring human bioelectric signals which should translate to faster detection of brain responses.
With needs related to mental challenges of an aging population, traumatic brain injury treatment, educating developmentally challenged children, thinking and memory problems (chemo brain) from cancer treatment, the need for a comprehensive solution is clear. Signal Advance's enhanced Neural Training system incorporates multiple stimulation modes which, combined with reduced detection delays means every training session is determined by the user's brain function, and the learning experience is custom tailored, in real-time, to the individual user automatically. The RESULT: expect better outcomes in less time.
"We are encouraged by initial discussions with contacts in MD Anderson Cancer Center and Home Instead Senior Care regarding the possibility of providing a cost effective means to help their patients and clients," said Chris M Hymel, Ph.D., President and Chief Executive Officer.
About Signal Advance, Inc.
Signal Advance, Inc., an emerging technologies company, has developed and is now commercializing its proprietary system to improve response time performance in signal detection. Target markets for the technology include medical, commercial, industrial, transportation and military. For more information, visit www.signaladvance.com
Forward-Looking Statements:
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements as a result of various factors and other risks, including those set forth in the Company's Form 10-K filed with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and the Company undertakes no obligation to update such statements.